These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36264329)
1. Comparative study between topical steroid alone versus combined fractional Erbium:YAG laser with topical steroid in treatment of alopecia areata. Shokeir HA; Yousry A; Ibrahim SMA Arch Dermatol Res; 2023 Mar; 315(2):241-247. PubMed ID: 36264329 [TBL] [Abstract][Full Text] [Related]
2. Treatment of alopecia areata with 2940-nm fractional erbium:yttrium-aluminum-garnet laser. Tanakol A; Oba MC; Uzuncakmak TK; Askin O; Kutlubay Z Dermatol Ther; 2020 Nov; 33(6):e13978. PubMed ID: 32633447 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study. Nassar A; Elradi M; Radwan M; Albalat W J Cosmet Dermatol; 2023 Apr; 22(4):1297-1303. PubMed ID: 36575890 [TBL] [Abstract][Full Text] [Related]
4. Fractional CO Abd ElKawy FAE; Aly SHM; Ibrahim SMA Dermatol Ther; 2022 Jul; 35(7):e15553. PubMed ID: 35509110 [TBL] [Abstract][Full Text] [Related]
5. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial. Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568 [TBL] [Abstract][Full Text] [Related]
6. Nd:YAG/Er:YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial. Zivanovic I; Gamper M; Fesslmeier D; Walser C; Regauer S; Viereck V BJOG; 2024 May; 131(6):740-749. PubMed ID: 38149520 [TBL] [Abstract][Full Text] [Related]
7. Topical 5% minoxidil versus combined erbium YAG laser and topical 5% minoxidil in androgenetic alopecia: A randomized controlled trial. Mokhtari F; Zavare Z; Iraji F J Cosmet Dermatol; 2023 Oct; 22(10):2737-2743. PubMed ID: 37574862 [TBL] [Abstract][Full Text] [Related]
8. The role of fractional laser-assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra-patient comparative randomized clinical trial. Meymandi SS; Safari A; Meymandi MS; Aflatoonian M J Cosmet Dermatol; 2024 May; 23(5):1663-1668. PubMed ID: 38321929 [TBL] [Abstract][Full Text] [Related]
9. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. Ucak H; Kandi B; Cicek D; Halisdemir N; Dertlıoğlu SB J Dermatolog Treat; 2012 Dec; 23(6):410-20. PubMed ID: 21787210 [TBL] [Abstract][Full Text] [Related]
10. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil. Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730 [TBL] [Abstract][Full Text] [Related]
12. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. Suchonwanit P; Rojhirunsakool S; Khunkhet S Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177 [TBL] [Abstract][Full Text] [Related]
13. The Use of a 1,540 nm Fractional Erbium-Glass Laser in Treatment of Alopecia Areata. Al-Dhalimi MA; Al-Janabi MH; Abd Al Hussein RA Lasers Surg Med; 2019 Dec; 51(10):859-865. PubMed ID: 31321800 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia. Dai R; Yang X; Su Y; Wu X Lasers Med Sci; 2024 May; 39(1):128. PubMed ID: 38724798 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study. Halim DA; Nayer M; El-Samanoudy SI; Raheem HMA; Ragab N Arch Dermatol Res; 2023 Apr; 315(3):505-511. PubMed ID: 36114868 [TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of fractional CO Prasanna H; Srinivas RT; Kuppuswamy SK; Keloji H; Ravikumar PT J Cutan Aesthet Surg; 2024; 17(1):34-40. PubMed ID: 38736853 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. Tosti A; Iorizzo M; Botta GL; Milani M J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039 [TBL] [Abstract][Full Text] [Related]
19. Comparative study between topical application of triamcinolone acetonide after fractional carbon dioxide laser versus microneedling in the treatment of resistant alopecia areata. Omar MM; Obaid ZM; Sayedahmed OME Dermatol Ther; 2022 Dec; 35(12):e15913. PubMed ID: 36209381 [TBL] [Abstract][Full Text] [Related]
20. Bimatoprost versus Clobetasol Propionate in Scalp Alopecia Areata: A Prospective Non-Randomized Open-Label Clinical Trial. Bhusal M; Bhattarai S; Thapa B; Shrestha PR; Sagar GC Indian Dermatol Online J; 2023; 14(2):221-225. PubMed ID: 37089845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]